J. Addington

The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis II. Baseline characteristics of the “prodromal” sample

Adrian Preda, T. McGlashan, M. Tohen, 2003, Schizophrenia Research.

Neuropsychological status of subjects at high risk for a first episode of psychosis

T. McGlashan, S. Woods, B. Christensen, 2004, Schizophrenia Research.